Mural Oncology
Adam Cutler is a Chief Financial Officer with a diverse background in the biopharmaceutical industry. Adam has held key financial roles in various companies such as Molecular Templates and Q32 Bio Inc. Additionally, Adam has served as a Board Member in companies like InMed Pharmaceuticals and Navidea Biopharmaceuticals. With a Bachelor of Arts in Economics from Brandeis University, Adam also has experience in biotechnology equity research from their time at Credit Suisse and Canaccord Genuity Inc.